ERBB2 and breast carcinoma: HER2 [4], [17], CD49f [6], AC133 [14] have also been shown to define or influence the activity of breast cancer stem cell populations and MUC1, in addition to delineating the mature luminal subpopulation of normal cells, has been shown to be overexpressed in a majority of breast cancers [42].